Demonstrações financeiras detalhadas de Lexicon Pharmaceuticals, Inc. (LXRX): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
Lexicon Pharmaceuticals, Inc. registou receitas de $49.8M no último exercício, com um CAGR de 5 anos de 15.7%.
Margens dos últimos 12 meses: margem bruta 98.9%, margem operacional -131.4%, margem líquida -147.4%.
Ao preço atual de $2.02, LXRX apresenta lucros negativos (P/L não significativo) e um ROE de -40.40%. A capitalização de mercado é de $897M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $83.3M | $90.3M | $63.2M | $322.1M | $24.0M | $298000 | $139000 | $1.2M | $31.1M | $49.8M |
| Custo da Receita | $164.0M | $1.9M | $2.5M | $3.2M | $1.9M | $55.0M | $52.5M | $59.0M | $616000 | $274000 |
| Lucro Bruto | -$80.6M | $88.4M | $60.7M | $318.8M | $22.1M | -$54.7M | -$52.4M | -$57.8M | $30.5M | $49.5M |
| P&D | $178.2M | $156.8M | $100.2M | $91.9M | $153.6M | $55.0M | $52.8M | $58.9M | $84.5M | $61.1M |
| Despesas Gerais e Administrativas | $43.0M | $66.2M | $63.8M | $56.8M | $47.2M | 0 | 0 | 0 | $131.9M | $37.3M |
| Despesas Operacionais | $221.2M | $223.0M | $164.0M | $177.4M | $69.9M | $32.3M | $48.4M | $114.0M | $227.6M | $98.4M |
| Lucro Operacional | -$137.2M | -$136.7M | -$103.3M | $141.4M | -$47.8M | -$87.1M | -$100.8M | -$171.8M | -$197.1M | -$48.9M |
| EBITDA | -$125.8M | -$125.3M | -$96.1M | $148.4M | -$41.1M | -$86.7M | -$100.0M | -$169.8M | -$184.3M | -$41.4M |
| Despesas com Juros | $6.6M | $7.0M | $20.8M | $20.7M | $14.5M | $802000 | $2.8M | $13.1M | $15.6M | $8.3M |
| Lucro Antes de Impostos | -$141.4M | -$141.7M | -$120.5M | $124.1M | -$58.6M | -$87.8M | -$101.9M | -$177.1M | -$200.4M | -$50.3M |
| Imposto | $4.5M | -$12.7M | 0 | -$6.0M | 0 | 0 | 0 | 0 | 0 | 0 |
| Lucro Líquido | -$141.4M | -$129.1M | -$120.5M | $130.1M | -$58.6M | -$87.8M | -$101.9M | -$177.1M | -$200.4M | -$50.3M |
| LPA | $-1.36 | $-1.23 | $-1.14 | $1.23 | $-0.63 | $-0.61 | $-0.62 | $-0.80 | $-0.63 | $-0.14 |
| LPA Diluído | $-1.36 | $-1.23 | $-1.14 | $1.11 | $-0.63 | $-0.61 | $-0.62 | $-0.80 | $-0.63 | $-0.14 |
| Ações em Circulação (Diluídas) | $103.9M | $105.2M | $105.8M | $116.7M | $110.8M | $145.7M | $165.7M | $221.1M | $320.0M | $363.1M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $14.2M | $5.5M | $21.1M | $692000 |
| Lucro Bruto | $14.2M | $5.2M | $21.0M | $653000 |
| Lucro Operacional | -$12.2M | -$14.8M | -$996000 | -$26.5M |
| EBITDA | -$10.5M | -$13.4M | $657000 | -$29.1M |
| Lucro Líquido | -$12.8M | -$15.5M | -$1.0M | -$31.8M |
| LPA | $-0.04 | $-0.04 | $-0.00 | $-0.07 |
| LPA Diluído | $-0.04 | $-0.04 | $-0.00 | $-0.07 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $346.5M | $310.8M | $160.1M | $36.1M | $126.3M | $64.1M | $46.3M | $22.5M | $66.7M | $34.3M |
| Investimentos de Curto Prazo | 0 | 0 | 0 | $235.5M | $26.0M | $22.7M | $92.0M | $147.6M | $171.3M | $61.9M |
| Contas a Receber | $7.5M | $4.8M | $5.9M | $56.5M | $395000 | $14000 | $28000 | $1.0M | $3.5M | $2.4M |
| Estoque | 0 | $1.9M | $4.7M | $4.2M | 0 | 0 | 0 | $381000 | $231000 | $281000 |
| Ativos Circulantes | $357.9M | $322.0M | $173.3M | $337.8M | $157.7M | $88.9M | $140.9M | $176.5M | $246.2M | $101.9M |
| Imobilizado | $19.4M | $17.7M | $15.9M | $14.0M | $295000 | $3.4M | $8.5M | $7.5M | $7.3M | $9.2M |
| Ágio | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M | $44.5M |
| Ativos Intangíveis | $53.4M | $51.9M | $50.1M | $19.7M | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Totais | $475.6M | $436.5M | $284.1M | $417.7M | $203.8M | $136.9M | $194.3M | $229.4M | $298.4M | $185.0M |
| Contas a Pagar | $52.9M | $38.8M | $12.1M | $12.2M | $5.5M | $9.2M | $10.4M | $14.4M | $14.8M | $3.1M |
| Dívida de Curto Prazo | $16.3M | $14.1M | $1.1M | $11.0M | $11.6M | 0 | 0 | 0 | 0 | $6.2M |
| Passivos Circulantes | $164.6M | $124.1M | $36.8M | $65.3M | $46.8M | $22.1M | $23.2M | $31.5M | $45.2M | $20.9M |
| Dívida de Longo Prazo | $85.2M | $231.6M | $243.9M | $234.2M | 0 | 0 | $48.6M | $99.5M | $100.3M | $49.4M |
| Passivos Totais | $318.2M | $384.4M | $310.5M | $300.6M | $47.4M | $23.3M | $77.2M | $136.3M | $152.5M | $77.4M |
| Reservas | -$1.25B | -$1.38B | -$1.47B | -$1.34B | -$1.40B | -$1.49B | -$1.59B | -$1.77B | -$1.97B | -$2.02B |
| Patrimônio Líquido | $157.4M | $52.1M | -$1.47B | $117.1M | $156.4M | $113.6M | $117.1M | $93.1M | $145.9M | $107.5M |
| Dívida Total | $101.4M | $245.7M | $245.0M | $246.8M | $12.8M | $2.3M | $55.3M | $106.1M | $108.4M | $62.2M |
| Dívida Líquida | -$245.1M | -$65.1M | $85.0M | -$24.8M | -$139.5M | -$84.5M | -$83.1M | -$64.0M | -$129.6M | -$34.0M |
| Capital de Giro | $193.2M | $197.9M | $136.6M | $272.4M | $110.9M | $66.8M | $117.7M | $145.0M | $200.9M | $81.0M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $49.7M | $34.3M | $38.1M | $40.9M |
| Ativos Totais | $205.9M | $185.0M | $268.8M | $250.1M |
| Passivos Totais | $85.8M | $77.4M | $66.0M | $75.5M |
| Patrimônio Líquido | $120.2M | $107.5M | $202.9M | $174.5M |
| Dívida Total | $64.9M | $62.2M | $57.7M | $59.3M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$141.4M | -$129.1M | -$120.5M | $130.1M | -$58.6M | -$87.8M | -$101.9M | -$177.1M | -$200.4M | -$50.3M |
| Depreciação e Amortização | $2.1M | $3.4M | $3.7M | $3.7M | $2.9M | $292000 | $427000 | $554000 | $534000 | $621000 |
| Compensação em Ações | $7.5M | $9.5M | $11.7M | $14.2M | $13.3M | $10.6M | $11.5M | $14.3M | $13.5M | $12.5M |
| Variação Capital de Giro | -$43.5M | -$59.3M | -$44.8M | -$58.3M | $31.1M | -$10.2M | $402000 | $2.7M | $14.2M | -$26.9M |
| Fluxo de Caixa Operacional | -$175.6M | -$185.4M | -$148.6M | $113.8M | -$143.0M | -$87.0M | -$88.9M | -$161.9M | -$178.8M | -$67.9M |
| CapEx | -$231000 | -$228000 | -$95000 | -$70000 | -$87000 | -$1.2M | -$1.3M | -$470000 | -$1.0M | 0 |
| Aquisições | 0 | 0 | 0 | $155.8M | $11.0M | -$3.3M | $69.8M | 0 | 0 | 0 |
| Recompra de Ações | -$621000 | -$1.7M | -$972000 | -$941000 | -$1.0M | -$2.7M | -$864000 | -$824000 | -$1.7M | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$175.9M | -$185.6M | -$148.7M | $113.7M | -$143.1M | -$88.2M | -$90.2M | -$162.4M | -$179.8M | -$67.9M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$23.8M | -$17.2M | -$14.7M | -$23.9M |
| CapEx | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$23.8M | -$17.2M | -$14.7M | -$23.9M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $3.4M | $2.8M | $3.1M | $6.4M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | +8.4% | -30.0% | +409.5% | -92.5% | -98.8% | -53.4% | +766.2% | +2481.5% | +60.2% |
| Crescimento Lucro Líquido (anual) | | +8.8% | +6.6% | +208.0% | -145.0% | -49.8% | -16.2% | -73.7% | -13.1% | +74.9% |
| Crescimento LPA (anual) | | +9.6% | +7.3% | +207.9% | -151.2% | +3.2% | -1.6% | -29.0% | +21.3% | +77.8% |
| Variação de Ações (anual) | | +1.3% | +0.6% | +10.3% | -5.1% | +31.4% | +13.8% | +33.4% | +44.7% | +13.4% |
| Crescimento FCF (anual) | | -5.6% | +19.9% | +176.5% | -225.8% | +38.3% | -2.2% | -80.1% | -10.7% | +62.3% |
| Margem Bruta | -96.8% | 97.9% | 96.1% | 99.0% | 92.0% | -18371.8% | -37681.3% | -4798.0% | 98.0% | 99.4% |
| Margem Operacional | -164.6% | -151.3% | -163.4% | 43.9% | -199.2% | -29224.8% | -72489.2% | -14265.0% | -634.2% | -98.2% |
| Margem EBITDA | -151.0% | -138.7% | -152.0% | 46.1% | -171.3% | -29081.9% | -71966.2% | -14099.3% | -592.9% | -83.1% |
| Margem Líquida | -169.7% | -142.9% | -190.7% | 40.4% | -244.1% | -29449.0% | -73341.0% | -14710.9% | -644.8% | -101.1% |
| Margem FCF | -211.0% | -205.5% | -235.3% | 35.3% | -596.2% | -29610.1% | -64875.5% | -13485.6% | -578.5% | -136.2% |
| Taxa Efetiva de Imposto | -3.2% | 8.9% | -0.0% | -4.8% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-1.69 | $-1.76 | $-1.41 | $0.97 | $-1.29 | $-0.61 | $-0.54 | $-0.73 | $-0.56 | $-0.19 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $103.9M | $105.1M | $105.7M | $106.2M | $110.8M | $145.7M | $165.7M | $221.1M | $320.0M | $363.1M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -40.40% |
| Retorno sobre capital investido | -23.00% |
| Retorno sobre ativos | -24.44% |
| Margem bruta | 98.85% |
| Margem operacional | -131.43% |
| Margem líquida | -147.38% |
Saúde financeira
| Dívida / Patrimônio | 0.34 |
| Liquidez corrente | 13.37 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -12.11 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -10.17 | -8.03 | -5.82 | 3.37 | -5.43 | -6.46 | -3.08 | -1.91 | -1.17 | -8.21 |
| P/VP | 9.13 | 19.93 | -0.48 | 3.76 | 2.42 | 5.05 | 2.70 | 3.63 | 1.62 | 3.88 |
| P/V | 17.24 | 11.50 | 11.11 | 1.37 | 15.80 | 1925.73 | 2277.34 | 281.00 | 7.60 | 8.38 |
| Margem Bruta | -96.8% | 97.9% | 96.1% | 99.0% | 92.0% | -18371.8% | -37681.3% | -4798.0% | 98.0% | 99.4% |
| Margem Operacional | -164.6% | -151.3% | -163.4% | 43.9% | -199.2% | -29224.8% | -72489.2% | -14265.0% | -634.2% | -98.2% |
| Margem Líquida | -169.7% | -142.9% | -190.7% | 40.4% | -244.1% | -29449.0% | -73341.0% | -14710.9% | -644.8% | -101.1% |